Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats.
- 2020-02
- Clinical Trial · n = 6
- Regulatory Toxicology and Pharmacology 110
- A. Metlakunta
- R. J. Soman
- PubMed: 31751640
- DOI: 10.1016/j.yrtph.2019.104538
- Low evidence
- Animal Study
the LD50 of Bacillus coagulans SNZ 1969 is more than 2000 mg/kg body weight and the NOAEL derived from this study was 1000 mg/kg/day for 28 days
- Effect
- Beneficial
- Effect size
- Small